# TailorMed

> TailorMed is a healthcare technology company that helps hospitals, clinics, pharmacies, infusion centers, life sciences companies, and patients find and use financial and medication-support programs. Its software and tech-enabled services automate patient identification, eligibility, enrollment, claims, free-drug workflows, fund management, and reporting. The company says its connected network reaches more than 75 million patients and has secured more than $7.4 billion in financial assistance since 2020.

- **Founded:** 2018
- **Headquarters:** New York, United States
- **Founders:** Israel (Srulik) Dvorsky (Co-Founder and CEO), Noa Inbar (Co-Founder and CTO)
- **Team size:** Approximately 190 employees in supplied company data; LinkedIn lists 51-200 employees.
- **Products:** TailorMed Core, TailorMed Connect, TailorMed Complete, TailorMed Amplify, TailorMed Alliance
- **Notable:** Company-reported $7.4 billion in financial assistance secured since 2020., Company-reported reach of more than 75 million patients across 945+ hospitals, 4,700+ clinics, and 3,100+ pharmacies., Acquired Vivor in 2021 to expand provider and pharmacy reach.

## Products & services

- **TailorMed Core** — Care-team software for financial navigation, automated eligibility and enrollment, renewals, claims, patient-assistance pharmacy workflows, analytics, and internal fund management.
- **TailorMed Connect** — A self-service patient experience for finding and enrolling in assistance programs, with education, reminders, and engagement capabilities.
- **TailorMed Complete** — A tech-enabled service that combines the platform with expert financial navigators who handle enrollment and related work for customers.
- **TailorMed Amplify** — Digital manufacturer solutions designed to improve access and time to therapy through the TailorMed network.
- **TailorMed Alliance** — A portfolio of partner solutions intended to connect complementary workflows and extend patient reach.

## Achievements

- Company-reported $7.4 billion in financial assistance secured since 2020.
- Company-reported reach of more than 75 million patients across 945+ hospitals, 4,700+ clinics, and 3,100+ pharmacies.
- Acquired Vivor in 2021 to expand provider and pharmacy reach.
- Highlands Oncology Group reported 28-day ROI, a 35% increase in patients assisted, and $1.3 million in claimed copay assistance in 2023.
- Named to the New York Digital Health 100 in 2023 and 2024.
- Achieved SOC 2 Type II compliance in 2022.

## Latest updates

- **2026-08** — Announced a partnership with RxSense to surface manufacturer assistance for 2,200+ brand-name medications within digital pharmacy marketplaces.
- **2025-10** — Introduced TailorMed Connect, a patient-facing experience for self-enrollment in affordability and support programs.
- **2025-06** — Expanded its KabaFusion partnership for home-infusion patient affordability.
- **2024-11** — Raised $40 million in combined equity and debt financing led by Windham Capital Partners, with the debt facility led by Poalim-tech.
- **2024-09** — Announced work with Prime Therapeutics / Magellan Rx to improve specialty pharmacy affordability.

## Links

- Website: https://www.tailormed.com
- LinkedIn: https://www.linkedin.com/company/tailormed---medical-journey-innovations
- Twitter/X: https://twitter.com/tailormedtweet
- Facebook: https://www.facebook.com/TailorMed.co/

---

Profile page: https://yespress.io/tailormed
Published by YesPress — https://yespress.io
Last updated: 2026-08-22